Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development

Go back to Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development
(NASDAQ: ELVN) Delayed: 59.01 +1.15 (1.99%)
Previous Close $57.86    52 Week High
Open $58.36    52 Week Low
Day High $60.55    P/E N/A 
Day Low $57.36    EPS
Volume 609,971